ST – Puma Biotechnology Partnership - Specialised Therapeutics
Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer | Business Wire
Puma Biotechnology, Inc. - SEC Filings - Annual Reports & Proxies
Marcus Morreale | LinkedIn
PUMA BIOTECHNOLOGY, INC.
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Puma Biotechnology: Finding Bullish Indications At The End Of 2019 (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
Neratinib Chapter
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Puma Biotech (PBYI) Q4 Loss Wider Than Expected, Sales Top | Nasdaq
Puma's (PBYI) Alisertib Gets FDA's Orphan Drug Tag for SCLC | Nasdaq
Reasons to Add Puma (PBYI) Stock to Your Portfolio Right Now | Nasdaq
pbyi-10k_20171231.htm
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity
Puma Biotechnology
Puma Biotech (PBYI) Q3 Earnings Top, Nerlynx Sales View Up
Puma Biotechnology, Inc. (PBYI) BCG Matrix Analysis
Puma Biotechnology: Alisertib Deal Alters My Strategy (NASDAQ:PBYI) | Seeking Alpha
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
